The
database was established to compare the time required to approve
new active substances, not new versions of existing drugs or
combinations that include them. Since the focus of previous analyses has been new therapeutic drugs, diagnostic products and
vaccines are also excluded. Consequently, a new drug is defined to
be any new therapeutic drug of chemical or biologic origin